Abstract. Synthesis of metal nanoparticles for improving therapeutic index and drug delivery is coming up as an attractive strategy in the mainstream of cancer therapeutic research. In the present study, curcumincapped copper nanoparticles (CU-NPs) were evaluated as possible inhibitors of in vivo angiogenesis, proangiogenic cytokines involved in promoting tumor angiogenesis along with inhibition of cell proliferation and migration of breast cancer cell line MDA-MB-231. The antiangiogenic potential was assessed using in vivo chorioallantoic membrane (CAM) model. 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)-based cytotoxicity assay was used to assess the effect of CU-NPs against proliferation of breast cancer cell line. The wound healing migration assay was used to evaluate the effects of CU-NPs on the migration ability of breast cancer cell line. Native curcumin (CU) was used as a reference compound for comparison purpose. The result of the present investigation indicates that CU-NPs could not demonstrate impressive antiangiogenic or anticancer activities significantly as compared to native CU. The possible mechanisms of experimental outcomes are discussed in the light of the methods of nanoparticle synthesis in concert with the current state of the art literature.
INTRODUCTION
Breast cancer is the most frequent cancer worldwide and the second leading cause of cancer-related death among females in the world (1) . The global concern of breast cancer exceeds all other cancers and the incidence rates of breast cancer are increasing (2) . Breast cancer in women has been a gloom issue in the medical history for decades (3) . Consequently, to address this challenge, there has been a growing interest towards the nanotechnology-based approaches for the development of targeted drug delivery system (4) . In the recent past, synthetic preparation and study of nanoparticles has gained a central importance in biomedical research owing to its wide range of potential therapeutic applications (5) . Nanotechnology is constantly being encouraged to overcome numerous limitations of conventional drug delivery systems since the latter fails to efficiently distinguish between cancerous and normal cells (6) . Targeting strategies of nanoparticles towards the cancerous tissues have concentrated on passive and active targeting. Several tumors possess deficient vasculature as well as poor lymphatic drainage due to the rapid growth of solid tumors. In case of passive targeting, noble metal nanoparticles can discharge into the tumor stroma through the fenestrations of the angiogenic vasculature, signifying targeting by improved permeation and retention and thus accumulation at the tumor site (7) . Moreover, the use of hydrophilic molecules, such as polyethylene glycol (PEG), can also significantly enhance their solubility, facilitate evading macrophage-mediated uptake and, therefore, evade exclusion from the fundamental circulation plus protect their carriers from enzymatic degradation when used in vivo (8) . For active targeting, nanoparticles can be easily improved with a broad range of biological moieties, such as antibodies, peptides, and DNA or RNA, to distinctively target extracellular and intracellular receptors (8) . The use of nanoparticles functionalized with several antibodies, such as monoclonal antibodies, has been depicted to effectively target particular cell surface proteins or receptors on cancer cells and formerly direct their antitumor action, inducing tumor cell death with least damage to healthy cells (9) .
Among the distinct nanoparticles that have been researched for remedial purposes against cancer are magnetic nanoparticles (10) . Much attention has been paid to the synthesis of metal nanoparticles because of their unique physical properties such as high surface-to-volume ratio, ease of synthesis, facile surface chemistry, and broad optical properties. The chemical properties such as enhanced catalytic activity formulate them suitable for drug delivery and targeting (11) . Because of their larger surface area, metal nanoparticles demonstrate several precise physicochemical properties that make them useful for the treatment of cancer such as their cytotoxicity after interaction with cancer cells. The antitumor mechanism of metal nanoparticles could work through the generation of reactive oxygen species, apoptosis, and necrosis (12) . Utilization of metal nanoparticles for killing of cancer cells seems to be relative with the nature and properties of metal nanoparticles. Several mechanisms of anticancer activities of metal nanoparticles have been proposed which includes hyperthermia, photothermal effect, and reactive oxygen species generation. The efficacy of nanoparticles also depends on the nature of the metal, size and shape of the nanoparticle, and its surface properties (13) .
As per definition, nanomaterials are materials or totals of materials in the size scope of 1-100 nm (14) . But in accordance with the consideration of the size and diameter of nanoparticles, they can be further categorized as fine particle which has the range of 100 to 2500 nm or ultrafine particles having the size of 1 to 100 nm (15) .
Naturally occurring therapeutically active biomolecules gained an immense attention for the synthesis of metal nanoparticles (16) . Among a variety of functional food ingredients, several polyphenols have demonstrated as anticancer agents and curcumin is one of them and known for its potent anticancer activity (17) . Curcumin is the active ingredient isolated from the rhizomes of turmeric (Curcuma longa) (18) . Curcumin is known for its intense antineoplastic movement against various tumors, including breast, prostate, and colon malignancies (19) . The chemopreventive feasibility of curcumin in all phases of carcinogenesis has gotten huge consideration on account of its low nonspecific danger to normal cells (20) . Curcumin is equipped for meddling with a few biochemical pathways included in the proliferation and survival of malignancy cells by straightforwardly and in an ambiguous way tying to distinctive targets (21) . Curcumin has been demonstrated as a blocker of NF-κB activation, which has been connected with proliferation, invasion, and inhibition of apoptosis (22) . Curcumin has long been perceived to have antiviral, antibacterial, antioxidant, anti-inflammatory, antiproliferative, and antiangiogenic exercises (23) .
Nevertheless, the leading issue restricting the exploitation of its conceivably valuable remedial impacts is its low bioavailability (24) . Various methodologies have been examined to deal with the solubility and bioavailability limits of curcumin and to enhance its solubility and to convey it to cancer cells (25) . Early clinical studies imply that nanoparticles are advantageous for cancer therapy attributable to its capability of more focused localization in the tumor microenvironment (26) . Therefore, to build up a curcumin molecule with superior bioavailability, different progressions in the preparations of curcumin nanoparticles have been further investigated for the application in cancer therapeutics (27) . A few techniques like encapsulation and transportation of curcumin have likewise been investigated to improve bioavailability and to accomplish the most response of this potentially useful molecule (28) . Alongside the nanoparticles, a scope of diverse nanovehicles, for example, liposomes, micelles, dendrimers, nanogels, and exosomes, has been utilized to encapsulate curcumin for enhanced bioavailability (29) .
In the present investigation, we have synthesized curcumin-capped copper nanoparticles. The comparative anticancer potential of curcumin (CU) and curcumin-capped copper nanoparticles (CU-NPs) was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)-based cytotoxicity assay and cell migration assay against human breast cancer cell lines. The antiangiogenic activity of CU and CU-NPs was tested using Human Angiogenesis I ELISA Strip Kit for profiling eight cytokines and in vivo chorioallantoic membrane model. The results of the present study demonstrate that, among CU and CU-NPs, CU was found to be having an effective anticancer potential as well as the effective inhibitor of angiogenesis as compared to CU-NPs. A discourse on limitations of synthetic methodology and the related biological activity of CU-NPs might act as a ready reference for designing and developing novel nanoparticles of therapeutic significance.
MATERIALS AND METHODS
Curcumin was purchased from HiMedia Laboratories, Mumbai, (MS), India. Leibovitz's L-15 medium was purchased from GIBCO™ Invitrogen (Grand Island, NY, USA). MTT and fetal bovine serum (FBS) were procured from Sigma-Aldrich (St Louis, MO, USA). Human Angiogenesis I ELISA Strip Kit was purchased from Signosis, Inc (Santa Clara, CA, USA). Fertilized chicken eggs were purchased from the local market at Nanded City (MS), and breast cancer cell line MDA-MB-231 was obtained from the National Centre for Cell Sciences (NCCS), Pune (MS), India. All other chemicals, solvents, and reagents used were of analytical grade and were procured from commercial sources.
Cell Culture
Human breast cancer cell line MDA-MB-231 free from any bacterial and fungal contamination was cultured in Leibovitz's L-15 medium, supplemented with 10% heatinactivated FBS, 2 mM glutamine, and without any antibiotics. Cells were maintained in an incubator at 37°C with 100% air before performing experiments (30) .
Synthesis of CU-NPs
The Creighton method was used for the synthesis of nanoparticles (31) . The synthesis of CU-NPs was carried out by the addition of curcumin (2 mM) in 10-15 ml of alcoholic solvent, followed by adding an aqueous solution of 0.002 mg of CuSO 4 with continuous stirring. Subsequently, the aqueous NaBH 4 was added within 20-30 min until effervesces stops. The resulting solution was then diluted with water and, finally, filtered and dried.
Characterization of CU-NPs

X-ray Diffraction Studies
An X-ray diffraction (XRD) measurement of CU-NPs was performed using Bruker D8 Advance diffractometer (Bruker AXS, Karlsruhe, Germany).
Fourier Transforms Infrared Analysis
CU-NPs were further characterized by Fourier transform infrared (FTIR) analysis. An IR spectrum was recorded as KBr pellets on FTIR Shimadzu spectrophotometer (Shimadzu, Japan 8400s) and PerkinElmer Spectrum version 100306 at Vishnu Chemical Pvt. Ltd., Hyderabad.
UV-Visible Spectroscopy
The progress and formation of CU-NPs was confirmed by UV-vis spectroscopy. The UV-visible absorption spectrum of CU-NPs was recorded in the wavelength region 200-700 nm using a UV-vis spectrophotometer (Shimadzu, Japan UV 1601).
Scanning Electron Microscopy Analysis
The morphological analysis of CU-NPs was carried out at STIC, Cochin University, Kerala, India, by using the scanning electron microscope JEOL model JSM-6390LV, USA.
Nanoparticle Size Measurement by Nanoparticle Tracking and Analysis System (NanoSight Ltd, UK)
The nanoparticle size was measured using Nanoparticle Tracking and Analysis (NTA) system (NanoSight Ltd, UK). The operational settings were carried out as per the manufacturer manual. The sample was diluted in ultrapure water to achieve the particle concentration of 10 7 -10 9 /ml. The calibrated sample was injected into LM 20 sample laser module (sample holder) by sterile syringes (32) . The particles present in the liquid sample at standard temperature and viscosity possess the Brownian motion; the NTA software calculates the size of particles by tracking and analyzing the motion of individual particles under laser light illumination. The NTA 2.3 software measured the diffraction of laser light by a particle and processed and generated the data. The data are generated in terms of the mean (average particle size measured) and mode (most frequently observed). The values obtained by processing the sample were recorded and the modal value (most frequent particle size) was taken as a size of the nanoparticle. In NTA, the Stokes-Einstein equation is the basis for calculation of particle size (33) .
Chorioallantoic Membrane Assay
The chorioallantoic membrane (CAM) assay was performed in an identical manner as depicted by (34) . The fertilized chicken eggs were purchased from local markets at Nanded City, and then the eggs were cleaned for the disinfection. Eggs were kept in a humidified incubator at 37°C. The eggs were positioned in a horizontal position and rotated several times. Egg development and morphology were analyzed with the help of egg Candler. On the ninth day of incubation, the eggs were opened on the snub side and a 1×1 cm window was cut into the eggshell. The individual concentrations (5, 15, 25 μM, respectively) of CU and CU-NPs prepared in dimethyl sulfoxide (DMSO, 0.05%, v/v) were applied (20 μl/disc) onto sterile glass discs (10 mm) separately and permitted to dry under laminar air flow conditions. The discs loaded with samples were inverted and applied over the CAM surface of 10-day-old embryos through the windows. Phosphate buffer saline (PBS) was utilized as a control. The windows were sealed with tape and the eggs were reincubated in a humidified incubator at 37°C. After 2 days of incubation, the CAMs were harvested and the vessels meeting the glass disc were counted under an Olympus make SZ 61TR Zoom Trinocular Microscope. The antiangiogenic effect was expressed using the equation 1−T/C, where T indicates the no. of blood vessels intersecting the disc treated with samples, while C indicates the no. of blood vessels intersecting the disc in control. The results obtained were expressed in percent values.
The control and treated CAMs were digitized using an Olympus make SZ 61TR Zoom Trinocular Microscope attached with CCD camera and an image capturing software Pinnacle v.6.0.2 (build 152). The digitized CAMs were further analyzed using the image analysis software AngioQuant v 1.33 (a MATLAB-based software tool for quantification of angiogenesis) for the analysis of number, length, size, and the junctions of the tubule complexes.
Assay for Inhibition of Pro-angiogenic Cytokines Using Human Angiogenesis I ELISA Strip Kit
The profiling of the inhibition of pro-angiogenic cytokines advancing tumor growth, such as tumor necrosis factor alpha (TNFα), insulin-like growth factor 1 (IGF1), vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), fibroblast growth factor-basic (FGFb), transforming growth factor beta (TGFβ), epidermal growth factor (EGF), and leptin, was completed according to the manufacturer's manual guidelines (Signosis, Inc., 528 Weddell Drive, Suite 5, Sunnyvale, CA 94089). In short, the fixing film over the plate was evacuated and 100 μl of standard, control, or sample was added to each well and incubated for 1 h at room temperature with gentle shaking. The contents were aspired from each well followed by washing the well by adding 200 μl of 1X assay wash buffer. The process of washing was repeated for three times. After the last wash, the remaining liquid was removed by inverting the plate against the clean paper towels. Then, 100 μl of diluted biotin-labeled antibody mixture-I was added to each well and incubated for 1 h at room temperature with gentle shaking. The contents were washed as described above. To each well, a 100 μl of diluted streptavidin-HRP conjugate was added and incubated for 45 min at room temperature with gentle shaking. Again, the contents were washed as described above. A substrate (100 μl) was added to each well and incubated for 25 min, followed by the addition of stop solution (50 μl). The change in color of the mixture from blue to yellow indicates the occurrence of reaction. The optical density of each well was recorded using Thermo make Automatic Ex-Microplate Reader (M 51118170) at 450 nm within 30 min. The percent activity of the pro-angiogenic cytokines were calculated using the equation 1−T/C, where T is the absorbance of the test sample, while C indicates the absorbance of the control sample. The results obtained were expressed in percentage.
Cell Migration Assay
Breast cancer cell (MDA-MB-231) migration was determined by using the wound healing assay as previously described (35) . Briefly, 1×10 4 cells/well was seeded in 24-well culture plates and incubated for 12 h with L-15 complete medium. Cell monolayer was wounded by scratching a line with sterile 10 μl pipette tip. The detached cells were removed by washing the cell monolayer with PBS. Then different concentrations of CU and CU-NPs (5, 15, 25 μM) containing complete medium were added. Photographs were taken at 0 and 12 h using an inverted Nikon microscope equipped with a digital camera.
MTT Cell Proliferation Assay
The effect of CU and CU-NPs on cell proliferation was examined by performing MTT assay described elsewhere (34) . In brief, the MDA-MB-231 cells were seeded into 96-well culture plate containing L-15 cell culture medium at a density of 1×10 4 cells/well. Different concentrations of CU and CU-NPs were added separately. Cells were incubated for 24, 48, and 72 h. After the treatment, cell culture medium was replaced with 50 μl of 2 mg/ml of MTT and incubated at 37°C for 4 h. The metabolically active cells reduce the yellow tetrazolium solution of MTT into formazan complex, which on addition of solvent turns in to a purple color. The formation of formazan product was recorded spectrophotometrically at 570 nm. The data were plotted as the concentration of CU and CU-NPs versus percentage of cell proliferation.
In Vitro Hemolytic Activity
The In vitro hemolytic activity of CU and CU-NPs was assessed as per the previously described method (36) . The hemolytic activities were determined using human red blood cells (37) . Briefly, fresh human erythrocytes were taken from healthy human volunteers and collected in the tubes containing EDTA (2 mg/ml) which acts as anticoagulant. The erythrocytes were harvested by centrifugation (Eppendorf Microcentrifuge 5418, Germany) for 10 min at 2000×g at 20°C; the plasma was discarded and washed thrice with PBS. Afterward, the PBS was added into the pellet to achieve 10% (v/v) erythrocytes/PBS suspension. The 10% suspension was diluted 1:10 in PBS. From every suspension, 100 μl was added to the different concentrations (5, 15, 25 μM) of CU and CU-NPs. Incubation was carried out for 1 h at 37°C. After incubation, the tubes were centrifuged for 10 min at 2000×g at 20°C and the 150 μl supernatant was taken into a microtiter plate and the absorbance was measured at 540 nm by using Thermo make Automatic Ex-Microplate Reader (M 51118170). Triton X-100 (1%, w/v) was used as a positive control.
The percentage of hemolysis was calculated by the following formula:
% Hemolysis ¼ Test compound-treated sample−Buffer-treated sample 1% Triton X-100-treated sample−Buffer-treated sample Â 100
RESULTS
Synthesis of CU-NPs
CU-NPs were prepared using curcumin as a stabilizing agent and NaBH 4 as a reducing agent as indicated in Scheme 1. The carbonyl group of CU helps in the reduction as well as stabilization of Cu-NPs. The effect of concentration of CU on the size of CU-NPs is also clearly indicated in the Scheme 1. The small-sized and rod-shaped Cu-NPs observed might be due to the capping of more CU moiety over the surface of copper, whereas the irregular size of CU-NPs might be associated with the smaller degree of aggregation of CU capping.
Characterization of CU-NPs
The formation of CU-NPs was confirmed by X-ray diffraction studies (XRD) which is further supported by the FTIR and UV-visible spectroscopy. Initially, the formation of CU-NPs was ascertained by the XRD pattern of CU-NPs as shown in Fig. 1 . The diffracted intensities were recorded from Scheme 1. Synthesis of CU-NPs Fig. 1 . X-ray diffraction pattern of CU-NPs peaks observed in the range of 20°to 30°for curcumin matches with the earlier report (38) .
Furthermore, these findings are in good agreement with results obtained with UV-visible spectroscopy as shown in Fig. 2 . The prepared CU-NPs demonstrate an absorption peak at around 420 nm which indicates the formation of CU-NPs, as there is no further clearly observable and measurable peak.
Further characterization of CU-NPs was carried out by FTIR. The FTIR spectra of CU and CU-NPs are shown in Fig. 3 . The broad peak at 3508 cm −1 indicates the presence of a hydroxyl group, the peak at 1726 cm −1 indicates the presence of a C=O group (carbonyl) in the curcumin, whereas the narrowly spaced doublet at 1628 and 1600 cm −1 can be assigned to the symmetric and unsymmetrical stretching of the alkene conjugated to 1,3-diketone group. The peak at 1501 cm −1 can be assigned to the stretching vibration of the aromatic ring. The FTIR spectra of Cu-NPs clearly indicate peak at 3501 cm −1 with the higher absorption intensity of the hydroxyl group. The formation of Cu-NPs further can be evidenced from the disintegration of peak at 1726 cm −1 which indicates the reduction of carbonyl group taking part in the encapsulation of Cu-NPs. After the encapsulation of Cu-NPs by CU, there is a shift in C=O peak at 1629 cm −1 appearing as a less intense band, towards higher frequency. The increase in the frequency may be due to coordination of enolic-OH of CU 
Chorioallantoic Membrane Assay
The profile of concentration-dependent antiangiogenic activities of CU and CU-NPs using the CAM model is summarized in Table I . The results obtained clearly demonstrate that CU was found to be more antiangiogenic as compared to CU-NPs in CAM studies. The dosedependent inhibition of angiogenesis by CU clearly demonstrates the efficacy of CU as an antiangiogenic agent as compared to CU-NPs in CAM model. CU showed the antiangiogenic activity in a dose-dependent manner such as 26.0±1.2% at 5 μM, 39.0±0.97% at 15 μM, and 54.0 ±1.5% at 25 μM, while CU-NPs showed the activity as 21.0±0.98%, 29.0±0.92%, and 43.0±0.88% at 5, 15, and 25 μM, respectively. The control and treated CAMs were digitized using Olympus make SZ 61TR Zoom Trinocular Microscope attached with CCD camera and an image capturing software Pinnacle v. 6.0.2 (build 152) as shown in (Fig. 6) . The digitized CAMs were further analyzed using image analysis software AngioQuant v 1.33 (a MATLAB-based software tool for quantification of angiogenesis) for the analysis of number, length, size, and the junctions of the tubule complexes. The results of the software analysis indicate that there was a significant reduction in the number, length, size and junctions of the tubule complexes in CU-treated CAMs as compared to treatment with CU-NPs. The representative images of CAMs exposed to different concentrations of CU and CU-NPs are shown in Fig. 6 .
CU and CU-NPs were evaluated for inhibition of selected pro-angiogenic cytokines such as TNFα, IGF1, VEGF, IL-6, FGFb, TGFβ, EGF, and leptin. These cytokines are recognized for their inclusion in the progression of tumor development, particularly by electing extensive vasculature for the promotion of tumor growth (39) . The results of cytokine inhibition using CU and CU-NPs are summarized in Table II . CU demonstrated a , Nanoparticle Tracking and Analysis (NTA) system. Plot representing the particle size (nm) and concentration (particle/ml). Value 173 is mode size (in nm) of observed nanoparticle 1035 Curcumin-Capped Copper Nanoparticles tron microscopy (SEM) also supports the synthesis of nanoparticles. The morphology of nanoparticles was shown as a small rod-like structure having the quantity of patches on the surface as shown in Fig. 4 . The diameter of the nanoparticles is found to be 178 nm. Further, the nanoparticle size measurement by nanoparticle tracking and analysis system using LM 20 demonstrates that the average CU-NP size measured is 173 nm as the mode value (most frequent particle size) as shown in Fig. 5 .
Inhibition of Pro-angiogenic Cytokines Supporting Tumor Growth
significant inhibition of cytokines such as TNFα, VEGF, IL-6, and FGFb as compared to CU-NPs. Thus, the cytokine inhibition studies of CU and CU-NPs clearly demonstrate the active involvement of CU in inhibition of selected pro-angiogenic peptides like TNFα, VEGF, IL-6, FGFb, and EGF as compared to CU-NPs.
Cell Migration Assay
We have examined the effect of CU and CU-NPs on the migratory behavior of a breast cancer cell line (MDA-MB 231) by performing cell migration assay. As shown in Fig. 7 , the microscopic images clearly showed that CU considerably inhibited migration of breast cancer cells as compared to CUNPs in a dose-dependant manner. CU significantly reduced the migration of breast cancer cell line at a concentration of 5, 15, and 25 μM over a period of 12 h; however, as shown in Fig. 8 , CU-NPs had no apparent influence on arresting the migration of breast cancer cells even after increasing its concentration. These results clearly indicate that CU possesses more antimigration potential as compared to CU-NPs.
MTT Proliferation Assay
We performed an MTT assay to study the effects of CU and CU-NPs on the proliferation of breast cancer cell line MDA-MB 231. Cell lines were treated with the different concentrations (5, 15, 25 μM) of CU and CU-NPs for a period of 24, 48, and 72 h. As shown in Fig. 9 , breast cancer cells treated with different concentrations of CU resulted in the decreased cell proliferation in a dose-and time-dependent manner. As shown in Fig. 10 , the growth of cells treated with different concentrations of CU-NPs resulted in the increased cell proliferation in a dose-and time-dependent manner.
In Vitro Hemolytic Activity
The hemolytic potential of CU and CU-NPs was assessed by incubating isolated erythrocytes with different concentrations of CU and CU-NPs (5, 15, 25 μM). As shown in Fig. 11 , all CU and CU-NP concentrations showed negligible hemolytic activity as compared to the positive control Triton X-100 and all were within the permissible limit of 5% for hemolysis (40) .
DISCUSSION
The present work was designed to evaluate the effect of CU and CU-NPs on human breast cancer cells, with a clear hypothesis that CU-NPs might improve the biological activity over native CU. The synthesis of metal nanoparticle is being constantly appreciated in several preclinical model studies for the development of novel and effective anticancer agents and a strategy for effective targeted drug delivery system (41) .
The most common techniques for the preparation and stabilization of metal nanoparticles are chemical, physical, and biological methods; the chemical methods such as chemical reduction, photochemical reduction, and electrochemical techniques are generally used for the preparation of nanoparticles. In the physical approach such as physical vapor condensation, arc discharge is the generally used method (42) . Literature have revealed that the size, morphology, stability, and properties including chemical and physical of the metal nanoparticles are altered strongly by the experimental conditions, the kinetics of interaction of metal ions with reducing agents, and the adsorption processes of stabilizing agent with metal nanoparticles (43) . Among the metal nanoparticles, copper nanoparticle synthesis is gaining momentum owing to its costeffectiveness as compared silver and gold (5). Results are expressed as the mean values from three independent experiments±standard deviation CU native curcumin, CU-NPs curcumin-capped copper nanoparticles
The metal nanoparticles are usually synthesized by controlled reduction of their particular salts in aqueous medium. It is reported that the use of excess reducing agents such as sodium citrate and sodium borohydride (NaBH 4 ) is the most widely recognized method for the synthesis of metal nanoparticles (42) . In the current study, the nanoparticles were synthesized by the Creighton method which is the routine strategy for the synthesis of silver nanoparticles, and modifications of this method can likewise be adjusted for the synthesis of nanoparticles from different metals such as Pt, Pd, Cu, Ni, and so forth. The specific strategy is depending upon the reduction capability of the source ion. The nanoparticles synthesized by using this method generally have a tendency to aggregate and require a capping agent for stabilization. The capping agent can be directly added into the solution at the time of reduction. The shape and size of nanoparticles depend upon the reaction condition and capping agent used (44) . The formation of nanoparticles was confirmed by the X-ray diffraction studies, FTIR spectral analysis, SEM analysis and nanoparticle size measurement by LM 20 (NanoSight Ltd, UK), and Nanoparticle Tracking and Analysis (NTA) system. The NTA system offers direct visualization, sizing, and counting of particles (32) .
Further, the antiangiogenic activity of CU and CU-NPs was assessed using the CAM assay. It is reported that the CAM model is a widely used in vivo model for determining the progress of angiogenesis (45) . Angiogenesis is the formation of new blood vessels, and therefore, it is a vital process required for both physiological and pathological conditions (46) . Angiogenesis is a fundamental perspective needed for the tumor development in cancer disease (47) . Broad network of capillaries is essential to provide the nutrients and oxygen for growing tumor (47) . Tumor-associated angiogenesis is intermediated by the migration and proliferation of host endothelial cells (48) . Angiogenesis is regulated by the various angiogenic factors (49) . Certain inducers of angiogenesis have been distinguished such as members of the fibroblast growth factor (FGF) family, vascular endothelial growth factor (VEGF), angiogenin, transforming growth factor alpha and beta (TGFα and TGFβ), tumor necrosis factor alpha (TNFα), interleukins, chemokines, and angiopoietins (50) . VEGF is the most important proangiogenic factor needed for tumor growth, invasion, and Results are expressed as the mean values from three independent experiments±standard deviation (SD) CU native curcumin, CU-NPs curcumin-capped copper nanoparticles, TNFα tumor necrosis factor alpha, IGF1 insulin-like growth factor 1, VEGF vascular endothelial growth factor, IL-6 interleukin 6, FGFb fibroblast growth factor-basic, TGFβ transforming growth factor beta, EGF epidermal growth factor Fig. 7 . Representative images showing the inhibitory effects of CU on breast cancer cell migration at concentrations of 5, 15, and 25 μM. Uniform scratches were created in cell monolayer which were treated with different concentrations of CU over a period of 12 h. Images were captured at ×10 magnifications using an inverted Nikon microscope equipped with digital camera metastasis (51). In our study, it was observed that CU was found to have more antiangiogenic potential as compared to CU-NPs in CAM studies. CU and CU-NPs were further evaluated for inhibition of selected cytokines such as TNFα, IGF1, VEGF, IL-6, FGFb, TGFβ, EGF, and leptin by using Human Angiogenesis I ELISA Strip Kit for profiling of eight different cytokines. These cytokines play a vital role in promotion of tumor growth, particularly by recruiting massive vasculature (39) . And the antiangiogenic study clearly demonstrates the involvement of CU in the inhibition process of angiogenesis by inhibiting the pro-angiogenic growth factors like TNFα, VEGF, IL-6, FGFb, and EGF. However, CU-NPs do not demonstrate significant antiangiogenic activity. Curcumin is described as a potent inhibitor of angiogenesis. It is reported that curcumin can downregulate all positive regulators of angiogenesis including angiogenin, EGF, FGF, G-CSF, PDGF, TNFα, and TGFβ, and cytokines, such as IL-1, IL-4, IL-6, and IL-8, can act either as stimulators or inhibitors, depending on their amounts, the tumor site, and the tumor microenvironment. Moreover, curcumin has been found to regulate angiogenesis by inhibiting either the production or action of these cytokines (52) . Invasion and migration are necessities for the development and metastasis of solid tumors (53) . Therefore, we have examined the effect of CU and CU-NPs on the migratory behavior of human breast cancer cells by performing cell migration assay. CU significantly reduced the migration of breast cancer cells in a concentration-dependent manner over a period of 12 h. However, CU-NPs had no any considerable effect on arresting the migration of cells even after increasing its concentration. Previous studies have shown that CU has accounted to inhibit the invasion and migration of breast cancer cells by various mechanisms, such as CU inhibited the invasive potential of MDA-MB-231 cells by downregulation of MMP-2, MMP-3 and MMP-9 and upregulation of tissue inhibitor metalloproteinase We performed an MTT assay to study the effects of CU and CU-NPs on the proliferation of breast cancer cell line. The principle of the assay is that a mitochondrial enzyme in living cells, succinate dehydrogenase, cleaves the tetrazolium ring and converts the MTT to an insoluble purple formazan wherein the amount of formazan produced is directly proportional to the number of viable cells (34) . Breast cancer cells treated with different concentrations of CU resulted in the inhibition of cell proliferation in a dose-and time-dependent manner. The growth of cells treated with different concentrations of CU was more significantly inhibited than the growth of cells treated with CUNPs. The literature reveled that CU is a potent anticancer agent because of its ability to obstruct various biochemical pathways which are associated with the proliferation of cancer cells by binding with the various targets (55) .
Furthermore CU and CU-NPs were evaluated for their toxicity towards the human erythrocytes by using the in vitro hemolytic assay. Plasma hemoglobin was quantified spectrophotometrically and it was directly proportional to the concentration of lysed blood cells, which can be directly associated with the hemolytic activity of the material. The results clearly demonstrated that both CU and CU-NPs have negligible toxicity against human erythrocytes. Our results are in agreement with the previous report describing the nonsignificant hemolytic activity of CU at 0.5-100 μM concentrations (40) . Almost similar kind of results are reported for a variety of copper-based particles such as nano-and micron-sized copper metal particles, a nano-sized binary copper-zinc alloy, and copper oxide nanoparticles (56) .
CU can bind with a broad range of molecular targets because of numerous aspects of its chemical structure (25) . It is reported that CU is surrounded by several functional groups. The aromatic ring system which consists of two hydrophobic phenol i.e., polyphenols connected by two α-and β-unsaturated carbonyl group. The central diketones form stable enols or are easily deprotonated and form enolates, while the α-and β-unsaturated carbonyl is a Michael acceptor and (19) . The phenolic methoxy groups, as well as the ketone and enol groups, present on the ends and in the middle of the molecule, respectively, can participate in strong hydrogen bonding interactions (57) .
The reviews of literature revealed that curcumin possess a wide array of biological applications. It envisioned that copper(II) conjugate of a synthetic analogue with non-enolizable diketone is more potent than curcumin in inhibiting TNF-induced NF-kB activation and proliferation (58) . Keeping this in mind, we prepared Cu-NPs expecting the potent biological activity. But in an attempt to evaluate the effect of CU and CU-NPs on human breast cancer cells, it turned out to be an illusion; the results clearly demonstrated that the native curcumin itself is more effective against breast cancer cell line as compared to CUNPs. Our result demonstrates the efficacy of CU with promising a ntiangiogenic, ant i pr oli f er a ti v e, a nd antimigratory potential as compared to CU-NPs. While describing the possible mechanism, it has been reported that curcumin analogues particularly tetrahydro-curcumin, hexahydro-curcumin, and octahydro-curcumin are found to be less active than curcumin in suppressing NF-kB activation and tetrahydro-curcumin was found to be less active than curcumin in preventing PMA-induced skin tumor promotion in mice also due to the reduction of the carbonyl group (59) . From the results, it can be stated that the presence of C=O (carbonyl) group seems to be a key factor for the manifestation of tested biological activity of curcumin. The reduction of C=O group due to aqueous NaBH 4 might be associated with suppressing the biological activity of Cu-NPs. Indeed, the 1,3-dicarbonyl group could be considered as the pharmacophore of curcumin.
CONCLUSION
Drug conveyance frameworks utilizing nanoparticles are appreciated as a promising methodology for enhancing the safety and bioavailability of curcumin. The basic aim of the present study was to evaluate the efficacy of CU-NPs as a potential anticancer and antiangiogenic agent in concert with native CU. However, the hypothesis that CU-NPs might demonstrate the impressive anticancer and antiangiogenic activity over native CU turned out to be an illusion. Perhaps, our study is the first report of its kind, focusing the significance of synthetic methodology of nanoparticle synthesis with the biological activity. Our results signify the importance of native curcumin as a promising antiangiogenic and anticancer (against MDA-MB 231) agent as compared to its CU-NPs. It seems from the results that reduction of the carbonyl group of curcumin due to aqueous NaBH 4 which is used as a common reducing agent for the synthesis of nanoparticles in the Creighton method retards the activity of CU-NP S . In context with the present investigation, it is indeed that the Creighton method for the synthesis of CU-NPs seems to be nonsignificant in concert with tested antiangiogenic and anticancer activities. Nanotechnology-based approaches are constantly appreciated for enhancing the biomedical applications and therapeutic index of bioactive molecules including curcumin. Therefore, there is the need to critically evaluate the nanotechnology-based approaches for maneuvering curcumin-like substances as effective bioactive molecule.
